Divis Laboratories Ltd (DIVISLAB)

Divis Laboratories Among Top Gainers - 14 Sep, 2023

Divis Laboratories Ltd saw a rise in stock prices, with the company emerging as one of the top gainers on the Nifty index.

Vaishali Recommends Buying Divi's Laboratories - 13 Sep, 2023

An analyst recommends buying Divi's Laboratories stock at ₹3,787 with a stoploss of ₹3,700 and a target price of ₹3,900.

Divis Labs Shows Positive Trend; Major Gainer on Nifty50 - 12 Sep, 2023

Divi's Laboratories Ltd showed a positive trend with support at ₹3700. It was among the major gainers on Nifty50.

Divi's Labs Shares Trade at 49% Discount to Historical PE - 07 Sep, 2023

Shares of Divis Laboratories Ltd are trading at a significant discount to their historical price-to-earnings ratio, but the stock's average target price suggests a potential downside of 10%.

Divis Laboratories Among Top Gainers on Nifty 50 - 06 Sep, 2023

Shares of Divi's Labs emerged as one of the top gainers on the Nifty 50, contributing to a rise in the Nifty Pharma index by around 1%.

Divi's Labs Among Top Laggards in Stock Market - 01 Sep, 2023

Divis Laboratories Ltd was among the top laggards in the stock market as investors booked partial profits off pharma names. The Nifty Pharma also fell due to this trend.

Mixed Day for Divi's Laboratories Stock - 24 Aug, 2023

Divi's Laboratories had a mixed day in the stock market as shares remained flat over the last month. Sukhani advised traders to buy the stock with a stop loss of Rs 3,600.

Divi's Labs Among Top Gainers in Nifty 50 - 23 Aug, 2023

Divi's Laboratories Ltd gained up to 1.55% and was among the top gainers of Nifty 50 along with other companies like L&T, LTI Mindtree and Cipla.

Mixed Sentiments for Divis Laboratories Ltd. - 22 Aug, 2023

Prabhudas Lilladher is bullish on Divi's Labs in the short term, but also introduced Sell Ideas. They recommend a stock-specific approach and avoiding sectors with weak fundamentals.

Divi's Laboratories Misses 1QFY24 Estimates, Earnings Reduced - 21 Aug, 2023

Divi's Laboratories missed 1QFY24 estimates due to lower sales in generics and custom synthesis. EBITDA margin expanded sequentially owing to cost management activities. Earnings for FY24/FY25 reduced by 3%/5%. Neutral rating maintained as valuation factors in earnings upside over the next two years.

Divi's Labs Stock Falls Over Sales Miss and Expensive Valuations - 17 Aug, 2023

Divi's Laboratories Ltd's Q1FY24 EBITDA was 12% below Prabhudas Lilladher's estimate led by lower revenues across segments. They have downgraded the stock to 'Reduce' from 'Hold' rating with a revised target price of Rs3,000/share. The stock has fallen over 5.3% in the last six trading sessions.

Mixed Day for Divis Laboratories Ltd - 16 Aug, 2023

Divi's Laboratories' Q1 net profit declined 49.3% YoY to Rs 356 crore, missing estimates. However, the company has been identified as a global cost champion for several molecules.

Divi's Labs Reports Disappointing Q1 Results - 14 Aug, 2023

Divi's Laboratories Ltd's Q1 profit fell by half, missing estimates due to pricing pressures. Despite this, the stock gained 1.87%. Technical analysis recommends a short Iron Condor strategy.

Divi's Labs Faces Weak Q1 Performance Expectations - 11 Aug, 2023

Divis Laboratories Ltd faces expectations of a weak Q1 performance due to high base and margin pressure, resulting in estimated net profit fall of 42.6% YoY.

Divi's Laboratories Ltd Experiences Shift in Market Sentiment - 10 Aug, 2023

The crossing of Divi's Laboratories Ltd's short-term and long-term moving averages signals a shift in market sentiment.

Divis Laboratories Stock Falls on Short Build-Up and Poor Performance - 09 Aug, 2023

Divis Laboratories Ltd's stock experienced a short build-up, resulting in it being one of the worst-performing stocks on the Nifty 50.

Positive Outlook for Divi's Laboratories Stock - 07 Aug, 2023

Experts recommend buying Divi's Laboratories with a stop loss of Rs 3,650 as the stock gains up to 2.87%. The company has shown positive growth potential.

Divi's Labs Among Top Gainers on Nifty 50 - 04 Aug, 2023

Divi's Laboratories Ltd was among the top gainers on Nifty 50 along with other companies such as Adani Enterprise, Adani Ports & Special Economic Zone, Eicher Motors, and Hindalco Industries. Additionally, Divi's Labs' trading P/E ratio is 54.15.

Divis Laboratories Gains on Nifty 50 Index - 03 Aug, 2023

Divis Laboratories Ltd showcases impressive market performance by surpassing its 20-day SMA and being recommended as a buy call by Sudarshan Sukhani.

Divis Laboratories Ends in Green Despite Market Fall - 02 Aug, 2023

Despite a market fall, Divis Laboratories Ltd managed to end in the green and was among the top gainers on the Nifty 50. A sell call was made earlier in the day.